O
DXCM icon

Ossiam’s DexCom DXCM Stock Holding History

Ossiam’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-269,700
Closed -$18.1M – 456
2025
Q3 		$18.1M Buy
269,700
+48,560
+22% +$3.84M 0.23% 85
2025
Q2 		$19.3M Sell
221,140
-6,127
-3% -$480K 0.22% 93
2025
Q1 		$15.5M Buy
227,267
+5,242
+2% +$428K 0.22% 73
2024
Q4 		$17.3M Buy
222,025
+15,610
+8% +$1.16M 0.3% 54
2024
Q3 		$13.8M Buy
206,415
+962
+0.5% +$79K 0.27% 69
2024
Q2 		$23.3M Buy
205,453
+192,367
+1,470% +$24.3M 0.44% 51
2024
Q1 		$1.82M Sell
13,086
-2,291
-15% -$288K 0.03% 257
2023
Q4 		$1.91M Buy
15,377
+1,722
+13% +$176K 0.03% 240
2023
Q3 		$1.27M Buy
13,655
+7,911
+138% +$892K 0.02% 303
2023
Q2 		$738K Sell
5,744
-1,610
-22% -$195K 0.01% 363
2023
Q1 		$854K Sell
7,354
-8,781
-54% -$983K 0.02% 309
2022
Q4 		$1.83M Buy
16,135
+4,086
+34% +$449K 0.05% 209
2022
Q3 		$970K Sell
12,049
-21,123
-64% -$1.79M 0.03% 263
2022
Q2 		$2.47M Sell
33,172
-3,884
-10% -$354K 0.07% 156
2022
Q1 		$4.74M Sell
37,056
-26,360
-42% -$2.88M 0.12% 114
2021
Q4 		$8.51M Buy
63,416
+29,424
+87% +$4.23M 0.22% 88
2021
Q3 		$4.65M Buy
33,992
+2,976
+10% +$375K 0.13% 117
2021
Q2 		$4M Buy
31,016
+1,196
+4% +$115K 0.11% 124
2021
Q1 		$2.68M Buy
29,820
+22,512
+308% +$2.11M 0.08% 147
2020
Q4 		$675K Sell
7,308
-1,300
-15% -$116K 0.02% 239
2020
Q3 		$887K Sell
8,608
-16,404
-66% -$1.71M 0.04% 202
2020
Q2 		$2.54M Buy
+25,012
New +$2.24M 0.16% 111

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Ossiam's DXCM Position: Q4 2025 in Review

Ossiam sold out of DexCom (DXCM) in Q4 2025, closing a stake of 269,700 shares — an estimated $18.1M sold.

Ossiam first reported a position in DXCM in Q2 2020 and held it in 22 quarters. The position peaked at $23.3M in Q2 2024. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Ossiam reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Ossiam sold 269,700 DexCom shares in Q4 2025, an estimated $18.1M.
  • Ossiam first reported a position in DexCom in Q2 2020 and held it in 22 quarters.
  • Ossiam's DexCom position peaked at $23.3M in Q2 2024.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Ossiam's 13F filing for Q4 2025, filed 13 Feb 2026.